Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
about
Meglitinide analogues for type 2 diabetes mellitusKir6.2 is required for adaptation to stress.Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of DiabetesCostus spicatus tea failed to improve diabetic progression in C57BLKS/J db/db mice, a model of type 2 diabetes mellitusIdentification of the human cytochromes P450 catalysing the rate-limiting pathways of gliclazide eliminationThe Efficacy of Ginseng-Related Therapies in Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-analysisRecent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive UpdateClinical utility in the treatment of type 2 diabetes with the saxagliptin/metformin fixed combinationSafety and efficacy of sitagliptin-metformin in fixed combination for the treatment of type 2 diabetes mellitusPharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjectsSaxagliptin overview: special focus on safety and adverse effectsDiabetes in African AmericansFactors associated with results and conclusions of trials of thiazolidinedionesEffect of switching to a high-deductible health plan on use of chronic medicationsAnti-Diabetic Effect of Portulaca oleracea L. Polysaccharideandits Mechanism in Diabetic RatsAre hypoglycaemia and other adverse effects similar among sulphonylureas?Vildagliptin: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties.Cost-efficient treatment for uninsured or underinsured patients with hypertension, depression, diabetes mellitus, insomnia, and gastroesophageal reflux.Diabetes: glycaemic control in type 2.Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes.Efficacy and safety of ginsam, a vinegar extract from Panax ginseng, in type 2 diabetic patients: Results of a double-blind, placebo-controlled study.Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeks.Predictive factors of durability to sitagliptin: Slower reduction of glycated hemoglobin, older age and higher baseline glycated hemoglobin.Sitagliptin added to stable insulin therapy with or without metformin in Chinese patients with type 2 diabetes.Zanthoxylum alkylamides ameliorate protein metabolism disorder in STZ-induced diabetic rats.Mesenchymal stem cell therapy in type 2 diabetes mellitus.Oral antihyperglycemic therapy for type 2 diabetes mellitus.Current therapeutic options in type 2 diabetes mellitus: a practical approachTargeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic DrugsPredetermined Anti-Diabetic Drug Regimen Adjustments during Ramadan Fasting: An Observational Study of Safety.Targeting sirtuins for the treatment of diabetesModulatory Effect of Rice Bran and Phytic Acid on Glucose Metabolism in High Fat-Fed C57BL/6N Mice.The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysisRelationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis.Thiazolidinediones: a 2010 perspective.Bioequivalence Comparison of Two Formulations of Fixed-Dose Combination Glimepiride/Metformin (2/500 mg)Tablets in Healthy VolunteersDapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial.A Novel Therapeutic Agent for Type 2 Diabetes Mellitus: SGLT2 Inhibitor.Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort studyChanges in oral antidiabetic prescriptions and improved glycemic control during the years 2002-2011 in Japan (JDDM32).
P2860
Q24245352-79F4B297-A286-4411-BFB2-986FD0BF5F07Q24538695-356DA357-0AD6-4D8B-957B-AC1828850BDBQ24642503-66441EA7-24DA-45D1-ADDD-6B3DDC1D292EQ24651966-6E0A506D-5881-4B61-87FC-823BF96A2DB3Q24670563-8697714E-B10E-4F09-B630-0BD6747D1833Q26766298-633D2714-75F3-4F9C-BEE0-DABCF9F92D58Q26798145-B8543DDC-74FC-464E-9E81-1E2BB6C6D609Q27026211-763BA816-1716-4F45-9D1E-483F338F3363Q27027877-E5101D61-384D-4E38-ABA4-7E8F186FD229Q28252893-D02C5B52-4BDE-4632-AE5A-06D5D42552CFQ28278863-824815F4-ED3C-4823-B30D-54A7498B5A0EQ28394087-DD200511-331D-4938-9501-BAB584106DCCQ28475588-4D60EF7D-2731-47E8-827B-6328EBA3BCD1Q28743191-6096695A-5100-433B-976B-757CF4485B84Q28828825-77CD2B43-8455-47AA-9DB3-0A4217AA949AQ31122704-4B429B59-BF8E-4F0C-9F20-0E9AEFF0107DQ33237060-CEB11DE7-AFB5-46F6-968C-060A12FEF97DQ33323489-E81ECCE3-4C0B-49AB-BE8E-2ABE9303B382Q33446693-4DAA7775-DB3A-4997-B9A7-1A4115FB5D26Q33562235-A9EA9E4C-FBBE-4F5E-8DBA-2487C9917594Q33585792-761C7A63-151F-46C3-8E5A-E9F6418C4CF6Q33603409-C391EC40-8D57-41C6-96A0-BD14B1BC72D6Q33628631-66873A55-1ACC-4126-BD84-ED5C4B23B2EBQ33633710-685DBF79-7C2C-4C24-9897-8DF1447BBA6FQ33654613-E40F816E-BA9D-48A4-9B24-8741FD9C95CAQ33691629-27CE8F13-B2B4-4E69-8AB5-C0FC527A4DF5Q33713451-44C0BCAC-B104-4BF3-B81D-BAD70DB4920EQ33723387-F41A7221-58E9-4778-AA37-984C5D569A87Q33809886-CCA517C1-0559-411E-A76A-95BAFF0F82F7Q33889887-4855C110-D098-4EBF-8E79-825A66EF48E8Q33946771-073F3875-4698-4748-A161-DE67A9FE38D2Q33983535-E7351C2F-53D9-4212-9E2E-837A8DF0D518Q34016145-992D6C3D-2D29-41C2-B365-CC6BC8D2CE23Q34056132-B2084890-2163-455F-AA57-D22BF2CE0ACCQ34121055-64BB49AD-3676-403A-9B4D-7CF5E3DCE68DQ34146068-B35E4A1A-FA02-483F-A7A9-E491C6D95A3BQ34153496-98F18D34-A970-4F2E-99A7-CE471BBC115EQ34161881-DE84B57A-F3CA-41D5-A0B4-29247C44D524Q34257350-159E5D6D-4FEC-4768-939B-E57AE9F0C2D8Q34299670-701DE9BD-7DB1-4747-A188-E63174EC6131
P2860
Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
@ast
Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
@en
Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
@nl
type
label
Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
@ast
Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
@en
Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
@nl
prefLabel
Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
@ast
Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
@en
Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
@nl
P356
P1476
Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
@en
P2093
Silvio E Inzucchi
P304
P356
10.1001/JAMA.287.3.360
P407
P577
2002-01-01T00:00:00Z